tetano
Editor, Senior Moderator
PLoS One
. 2024 Dec 27;19(12):e0313042.
doi: 10.1371/journal.pone.0313042. eCollection 2024. Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis
Marwa A Ali[SUP] 1 2 [/SUP], Olfat G Shaker[SUP] 3 [/SUP], Eman M Ezzat[SUP] 4 [/SUP], El Shaimaa Gomaa Ali[SUP] 5 [/SUP], Mahmoud I Aboelor[SUP] 6 [/SUP], Mona I Ahmed[SUP] 7 [/SUP], Essam A Hassan[SUP] 8 [/SUP], Doaa Y Ali[SUP] 9 [/SUP], Heba Mostafa Ahmed[SUP] 9 [/SUP], Abeer A Khalefa[SUP] 10 [/SUP], Rasha A Hussein[SUP] 11 [/SUP], Ahmed Fathy Elkhateeb[SUP] 12 [/SUP], Esam Ali Mohamed[SUP] 1 [/SUP]
Affiliations
Background: The SARS-CoV-2 virus's frequent mutations have made disease control with vaccines and antiviral drugs difficult; as a result, there is a need for more effective coronavirus drugs. Therefore, detecting the expression of various diagnostic biomarkers, including ncRNA in SARS-CoV2, implies new therapeutic strategies for the disease.
Aim: Our study aimed to measure NEAT-1, miR-374b-5p, and IL6 in the serum of COVID-19 patients, demonstrating the correlation between target genes to explore the possible relationship between them. Also, the association between target genes and patients' clinical findings and radiological severity indices will be explored.
Patients and methods: The current study included 48 COVID-19-infected individuals and 40 controls. Quantitative real-time PCR (qPCR) was performed to detect lncRNA NEAT-1 and miRNA374b-5p fold change (FC) in the participants' sera. Enzyme-Linked Immune Sorbent Assay (ELISA) is used to detect IL6.
Results: Our results showed statistical significance with lower levels of (NEAT-1) [ median (range) = 0.08 (0.001-0.602)], and (miR374b-5p) [ median (range) = 0.14 (.01-7.16)] while higher IL-6 levels [ median (range) = 41.3 (7.2-654) pg/ml] when compared to controls with p-value <0.001. Serum level of NEAT-1 correlates negatively with IL-6 level (r = -.317, P = .008). ROC curve analysis revealed that sensitivity and specificity tests for NEAT-1 and IL-6 levels in the diagnosis of cases illustrated a sensitivity of (100% and 97.9%) and a specificity of (85% and 100%) at cut-off values (0.985 and 12.55), respectively. In comparison, miR374b-5p showed sensitivity and specificity of around 85% in distinguishing COVID-19 patients from controls. No significant association was detected between target genes and radiological severity indices.
Conclusions: Our study is the first to detect decreased NEAT-1 and miR374b-5p expression in COVID-19 patients' serum. There was also an increase in IL6 levels. There is a negative correlation between NEAT-1 and IL6 in COVID-19 patients.
. 2024 Dec 27;19(12):e0313042.
doi: 10.1371/journal.pone.0313042. eCollection 2024. Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis
Marwa A Ali[SUP] 1 2 [/SUP], Olfat G Shaker[SUP] 3 [/SUP], Eman M Ezzat[SUP] 4 [/SUP], El Shaimaa Gomaa Ali[SUP] 5 [/SUP], Mahmoud I Aboelor[SUP] 6 [/SUP], Mona I Ahmed[SUP] 7 [/SUP], Essam A Hassan[SUP] 8 [/SUP], Doaa Y Ali[SUP] 9 [/SUP], Heba Mostafa Ahmed[SUP] 9 [/SUP], Abeer A Khalefa[SUP] 10 [/SUP], Rasha A Hussein[SUP] 11 [/SUP], Ahmed Fathy Elkhateeb[SUP] 12 [/SUP], Esam Ali Mohamed[SUP] 1 [/SUP]
Affiliations
- PMID: 39729489
- PMCID: PMC11676515
- DOI: 10.1371/journal.pone.0313042
Background: The SARS-CoV-2 virus's frequent mutations have made disease control with vaccines and antiviral drugs difficult; as a result, there is a need for more effective coronavirus drugs. Therefore, detecting the expression of various diagnostic biomarkers, including ncRNA in SARS-CoV2, implies new therapeutic strategies for the disease.
Aim: Our study aimed to measure NEAT-1, miR-374b-5p, and IL6 in the serum of COVID-19 patients, demonstrating the correlation between target genes to explore the possible relationship between them. Also, the association between target genes and patients' clinical findings and radiological severity indices will be explored.
Patients and methods: The current study included 48 COVID-19-infected individuals and 40 controls. Quantitative real-time PCR (qPCR) was performed to detect lncRNA NEAT-1 and miRNA374b-5p fold change (FC) in the participants' sera. Enzyme-Linked Immune Sorbent Assay (ELISA) is used to detect IL6.
Results: Our results showed statistical significance with lower levels of (NEAT-1) [ median (range) = 0.08 (0.001-0.602)], and (miR374b-5p) [ median (range) = 0.14 (.01-7.16)] while higher IL-6 levels [ median (range) = 41.3 (7.2-654) pg/ml] when compared to controls with p-value <0.001. Serum level of NEAT-1 correlates negatively with IL-6 level (r = -.317, P = .008). ROC curve analysis revealed that sensitivity and specificity tests for NEAT-1 and IL-6 levels in the diagnosis of cases illustrated a sensitivity of (100% and 97.9%) and a specificity of (85% and 100%) at cut-off values (0.985 and 12.55), respectively. In comparison, miR374b-5p showed sensitivity and specificity of around 85% in distinguishing COVID-19 patients from controls. No significant association was detected between target genes and radiological severity indices.
Conclusions: Our study is the first to detect decreased NEAT-1 and miR374b-5p expression in COVID-19 patients' serum. There was also an increase in IL6 levels. There is a negative correlation between NEAT-1 and IL6 in COVID-19 patients.